When undergoing In Vitro Fertilization (IVF), the thickness of the endometrial lining is a crucial factor for the successful implantation of the embryo. If the lining is too thin, it can significantly reduce the chances of a successful pregnancy. Understanding how to increase endometrial thickness for IVF can help improve the success rate of this treatment, especially when you’re considering the best IVF in Bangalore.
In this blog post, we’ll explore various methods to improve endometrial thickness, including lifestyle changes, dietary adjustments, and medical interventions, which will be helpful for your IVF journey.
The endometrium is the inner lining of the uterus, which thickens each month in preparation for a potential pregnancy. For successful embryo implantation during IVF, a lining that measures between 7-11 mm is generally considered ideal. Anything less can lower the chances of implantation and, consequently pregnancy.
So, why is endometrial thickness so important for IVF? A thick, well-developed endometrial lining provides a nutrient-rich environment for the embryo to implant and grow. Insufficient thickness can result in implantation failure, even if the embryo is of high quality. Therefore, understanding and addressing factors that influence endometrial thickness for IVF can make a significant difference in treatment outcomes.
1. Increase or Optimise Oestrogen Dosing
The first and most direct intervention for a thin lining in a medicated FET cycle is increasing the dose or changing the route of oestrogen administration.
How it works: Oestrogen is the primary driver of endometrial growth. The lining grows in direct response to circulating oestrogen levels. If oral oestrogen is not producing adequate lining growth, the most common reason is absorption variability not every patient absorbs oral oestrogen at the same rate.
Protocol adjustments used at Janisthaa IVF:
– Increasing oral oestrogen from 2mg twice daily to 4mg three times daily
– Switching from oral to **vaginal oestrogen** (Progynova vaginal / Oestrogel) — vaginal administration bypasses first-pass liver metabolism, delivering higher local oestrogen concentration
– Adding transdermal oestrogen patches (Estradot / Climara) — particularly useful for patients who have failed to respond to oral dose increases
– Combining oral + vaginal routes for maximum absorption in difficult cases
Evidence: Vaginal oestrogen supplementation in poor responders has been shown in multiple studies to increase endometrial thickness by 1–3mm compared to oral-only protocols, with improved trilaminar pattern development.
Who benefits most: Patients whose lining fails to reach 7mm by Day 12 of a standard medicated FET cycle, and patients with previous failed FET cycles due to thin lining despite standard dosing.
2. Sildenafil (Viagra) – Vaginal Administration
This is the most evidence-supported adjuvant therapy for thin endometrium that does not respond adequately to oestrogen optimisation alone.
How it works: Sildenafil citrate — the active ingredient in Viagra — is a phosphodiesterase-5 (PDE5) inhibitor. When administered vaginally, it increases nitric oxide production in the uterine vasculature, which causes vasodilation of the uterine blood vessels, increasing blood flow to the endometrium. Improved blood flow enhances oestrogen delivery to the endometrial tissue and supports lining development.
Dosing protocol: 25mg vaginal suppository, 4 times daily, starting from Day 1 of oestrogen administration and continuing until the transfer day. Oral sildenafil has not been shown to be effective the vaginal route is critical.
Evidence: A 2018 meta-analysis published in *Human Reproduction* found that vaginal sildenafil increased endometrial thickness by a mean of 1.6mm in patients with thin endometrium, with improved blood flow parameters on Doppler ultrasound. A 2022 RCT in JARG confirmed improved implantation rates in patients receiving vaginal sildenafil alongside oestrogen versus oestrogen alone.
Side effects: Minimal with vaginal administration occasional local irritation. The systemic absorption is very low compared to oral use, so cardiovascular side effects are rare.
Who benefits most: Patients with consistently thin lining (below 7mm) despite optimised oestrogen dosing, and those with poor uterine blood flow on Doppler scan. Used in approximately 20–30% of FET cycles at specialist fertility centres.
3. Low-Dose Aspirin
A simple, inexpensive, and widely used adjuvant that improves uterine blood flow by inhibiting platelet aggregation and promoting prostaglandin-mediated vasodilation.
How it works: Aspirin (75mg, baby aspirin dose) inhibits thromboxane A2 a potent vasoconstrictor while leaving prostacyclin synthesis relatively intact. The net effect is vasodilation of uterine arteries, improved perfusion of the endometrium, and theoretically better oestrogen delivery to endometrial tissue.
Protocol: 75mg aspirin daily, started from the first day of oestrogen administration. Most protocols continue through to the pregnancy test; some continue through the first trimester in recurrent implantation failure cases.
Evidence: While individual studies have produced mixed results, a 2021 Cochrane review found low-dose aspirin to be associated with a modest improvement in endometrial thickness and uterine blood flow parameters in IVF patients. The low cost and minimal side effect profile make it a standard addition in most thin-lining protocols.
Who benefits most:Used routinely as a first-line adjuvant in all FET cycles with borderline or thin lining. Also considered for patients with elevated clotting markers (elevated Factor V Leiden, antiphospholipid antibodies) in whom aspirin serves a dual purpose.
4. Vitamin E Supplementation
A natural antioxidant that supports endometrial blood flow and may improve lining thickness through its vasodilatory and antioxidant mechanisms.
How it works: Vitamin E (tocopherol) acts as an antioxidant, reducing oxidative stress in the endometrial tissue. It also has mild vasodilatory properties promoting nitric oxide release in vascular smooth muscle, similar in mechanism to sildenafil but significantly milder. It may also support progesterone receptor expression in the endometrium.
Dosing: 400–800 IU Vitamin E daily (as alpha-tocopherol), started at least 4 weeks before the anticipated transfer cycle. Some protocols use it continuously through the IVF stimulation phase.
Evidence: A 2016 study in the *Journal of Reproduction and Infertility* found that patients supplementing with Vitamin E showed significant improvement in endometrial thickness and blood flow compared to controls. A 2020 RCT found Vitamin E supplementation to be associated with improved endometrial receptivity markers in thin endometrium patients.
Who benefits most: Patients with borderline thin lining (7–8mm) who are looking for safe, non-invasive adjuvant support. Best used in combination with other methods rather than as a standalone intervention for severely thin endometrium.
5. L-Arginine Supplementation
An amino acid precursor to nitric oxide the molecule responsible for vascular smooth muscle relaxation and improved blood flow L-arginine supports uterine perfusion through a complementary pathway to sildenafil.
How it works: L-arginine is converted to nitric oxide by the enzyme nitric oxide synthase (NOS). Nitric oxide causes relaxation of uterine vascular smooth muscle, increasing blood flow to the endometrium. Unlike sildenafil, which inhibits the breakdown of the signalling molecule, L-arginine increases its production upstream.
Dosing: 6g per day (typically 2g three times daily), started 4–6 weeks before the FET cycle.
Evidence: A 2002 study in *Human Reproduction* found that L-arginine supplementation in IVF patients with thin endometrium improved uterine blood flow and endometrial thickness, with improved implantation and pregnancy rates. More recent evidence supports its combination with Vitamin E and low-dose aspirin as a “vascular support trio” for thin lining cases.
Who benefits most: Patients with documented poor uterine blood flow on Doppler ultrasound. Best combined with Vitamin E and aspirin as a first-line non-pharmacological approach. Contraindicated in patients with herpes simplex virus L-arginine may trigger outbreaks.
6. Platelet-Rich Plasma (PRP) Intrauterine Infusion
The most advanced and increasingly evidence-supported intervention for patients with severely thin or refractory endometrium who have not responded to oestrogen optimisation and vascular adjuvants.
How it works: PRP (Platelet-Rich Plasma) is prepared from the patient’s own blood a sample is centrifuged to concentrate the platelets, which contain growth factors including PDGF, VEGF, EGF, and TGF-β. These growth factors are directly injected into the uterine cavity via a thin catheter (similar to an embryo transfer catheter). They stimulate endometrial regeneration, angiogenesis (new blood vessel formation), and proliferation of endometrial stem cells.
Procedure: Performed as an outpatient procedure without anaesthesia. A blood sample (approximately 20ml) is taken, centrifuged, and the PRP fraction (approximately 3–4ml) is injected into the uterine cavity under ultrasound guidance. Typically performed on Day 10–12 of the FET cycle, 48–72 hours before the planned transfer day.
Evidence: A 2019 meta-analysis in *Fertility and Sterility* analysed 5 RCTs and found PRP intrauterine infusion to significantly improve endometrial thickness (mean increase of 1.98mm) and clinical pregnancy rates in patients with thin refractory endometrium. A 2023 systematic review confirmed a significant improvement in live birth rates in PRP-treated patients compared to controls.
Who benefits most: Patients with a history of thin lining despite multiple oestrogen-optimised FET cycles, patients with Asherman syndrome or post-surgical scarring, and patients who have had two or more failed transfers despite adequate-appearing stimulation protocols.
At Janisthaa IVF: PRP intrauterine infusion is offered as part of our thin endometrium protocol when standard oestrogen optimisation and vascular adjuvants have not produced a lining above 7mm by Day 12.
7. Granulocyte Colony-Stimulating Factor (G-CSF) Intrauterine Infusion
A cytokine (immune signalling protein) that promotes endometrial regeneration through a different mechanism to PRP particularly relevant for patients with endometrial damage related to previous surgeries or infections.
How it works: G-CSF (Filgrastim) recruits bone marrow-derived stem cells to the endometrium, promoting regeneration of damaged or scarred endometrial tissue. It also stimulates uterine natural killer (uNK) cells, which play a role in early implantation. Unlike PRP which works primarily through growth factor signalling G-CSF works through immune-mediated tissue regeneration.
Procedure: G-CSF (300mcg/1ml) is infused directly into the uterine cavity via catheter on Day 9–11 of the FET cycle, in a procedure similar to PRP infusion. No anaesthesia required.
Evidence: A 2020 meta-analysis in *Reproductive BioMedicine Online* found G-CSF infusion to significantly increase endometrial thickness and improve clinical pregnancy rates in thin endometrium patients, with a mean thickness improvement of 2.1mm. Combination PRP + G-CSF protocols are used in the most refractory cases.
Who benefits most: Patients with thin endometrium related to Asherman syndrome, prior tuberculosis affecting the endometrium (endometrial TB is more prevalent in India than commonly recognised), or post-D&C scarring. Also used when PRP alone has not produced adequate response.
8. Lifestyle Modifications – Diet, Exercise, and Stress Reduction
While lifestyle changes alone rarely resolve clinically significant thin endometrium, they support the mechanisms through which medical interventions work and for borderline cases (7–8mm), targeted lifestyle changes can make the difference.
Blood flow-supporting diet:
Iron-rich foods – spinach, lentils (dal), rajma, liver, beetroot support haemoglobin and tissue oxygenation
Nitrate-rich vegetables – beetroot juice, leafy greens, pomegranate support nitric oxide production (the same pathway as L-arginine and sildenafil)
Healthy fats – avocado, walnuts, cold-pressed sesame oil support oestrogen metabolism and vascular health
Vitamin E-rich foods – sunflower seeds, almonds, olive oil complement supplementation
Exercise:
– Walking 30 minutes daily increases uterine blood flow through systemic cardiovascular improvements
– Yoga poses that increase pelvic circulation — particularly inversions and hip-opening poses — have theoretical benefit, though direct evidence in endometrial thickness is limited
– Avoid high-intensity exercise during the FET stimulation phase — excessive cortisol can impair oestrogen signalling
Avoid:
– Smoking — nicotine causes vasoconstriction and is one of the most well-documented causes of thin endometrium. Even passive smoking impairs uterine blood flow
– Alcohol — impairs oestrogen metabolism in the liver
– NSAIDs (ibuprofen, diclofenac) during the stimulation phase — prostaglandin inhibitors may impair uterine vasodilation. Paracetamol is the safe alternative
Stress reduction:
Chronic physiological stress elevates cortisol, which competes with progesterone receptors and may impair oestrogen signalling. Evidence for psychological interventions directly improving endometrial thickness is weak but stress-reduction measures (adequate sleep, reduced work hours in the two weeks before transfer, mindfulness) support the overall hormonal environment.